| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843589 | Actas Urológicas Españolas | 2014 | 8 Pages |
Abstract
According to this meta-analysis, chemotherapy with additional estramustine increased the PSA response rate. However, it increased the risk of grade 3 or 4 adverse effects such as nausea/vomiting and cardiovascular events, and the overall survival was not improved for castration-resistant prostate cancer patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
C. Zhang, T. Jing, F. Wang, X. Gao, C. Xu, Y. Sun,